Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.
Novel synthesis of Roxadustat intermediate via m-bromobenzaldehyde. High yield, eco-friendly process suitable for industrial scale-up and cost reduction.
Patent CN116332900B reveals a catalyst-free olefin synthesis using visible light. Offers cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN109896924B details a high-yield atmospheric pressure synthesis for Vitamin A intermediates, offering significant cost reduction and supply chain reliability.
Patent CN116120427B reveals high-yield solid-phase synthesis. Offers cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN115108932A reveals a novel Ru-catalyzed oxidative amidation using DMF. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN108147989B reveals a one-pot synthesis of beta-amino ketones using allyl alcohols, offering high yields and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103687489A reveals a safer, scalable route for 5-azaspiro[2.4]heptane-6-carboxylic acid, eliminating pyrophoric reagents for reliable HCV inhibitor supply.
Patent CN102344351B reveals a novel biaryl chalcone synthesis with V-shaped conformation for superior antitumor activity. Discover scalable routes and cost-effective manufacturing strategies.
Patent CN115260153B reveals high-yield synthesis for EGFR inhibitors. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101098880B reveals improved yield and purity for 13-deoxyanthracyclines reducing cardiotoxicity risks via novel reduction methods.
Patent CN111635437B reveals a novel palladium catalyst enabling mild, one-pot synthesis of alpha-methylene-gamma-butyrolactones, offering significant cost reduction in fine chemical manufacturing.
Novel acid-catalyzed one-pot synthesis patent CN106883152A offers high yield and atom economy for reliable pharmaceutical intermediate supply chains.
Novel catalytic route for posaconazole reduces impurities and cost. Reliable supply chain partner for high-purity antifungal API manufacturing.
Patent CN1898255B details a novel Wittig-HWE route for 4-substituted pyridines, offering cost reduction and scalable manufacturing for agrochemical and pharma intermediates.
Patent CN113831330B reveals a green three-step synthesis route for alpha-glucosidase inhibitors, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN103012074B reveals a high-yield synthesis method offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN103965122A reveals a mild silver-catalyzed nitration method for quinoxaline derivatives, offering high selectivity and supply chain advantages for fine chemical manufacturing.
Patent CN108314646B reveals a novel Pd/Ni-MOF catalyst for Apalutamide intermediates, offering high purity, recyclability, and significant cost reduction in API manufacturing.
Patent CN104313073A reveals high-yield biocatalytic route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.